Core Insights - The article discusses the recent seed round financing of Meiyin Intelligent Technology Co., Ltd., which raised tens of millions of yuan to develop AI-driven disease risk prediction and health management solutions [4][5]. Company Overview - Meiyin Intelligent focuses on utilizing AI technology for disease risk prediction and health management, with its core product being a disease risk prediction platform based on its self-developed large model [4]. - The company was incubated at Peking University Science Park and aims to provide AI-driven insurance and disease risk management solutions for individuals at risk of severe and chronic diseases [4]. Technology and Innovation - The company's self-developed DP-LLM model supports multimodal medical data and quantifies individual future disease risks, covering hundreds of diseases and thousands of risk factors [4]. - The CEO, Guo Xiaoyu, emphasizes the shift from traditional medical AI to generative models that can predict future health conditions based on historical health data [5]. - The model allows for more precise segmentation of insurance products, enabling coverage for individuals with early disease risks who were previously excluded [5]. Market Strategy - Meiyin Intelligent is currently focusing on commercial insurance as a payment channel, collaborating with government departments and large insurance companies to enhance health insurance products [6]. - The company plans to monetize through B2B technology service fees, C2C subscriptions, and risk-sharing models, aiming to reach more end-users [6]. Team and Expertise - The founding team possesses a strong academic background and practical experience in the medical AI field, with Guo Xiaoyu having over 10 years of experience in R&D and commercialization [7]. - The team includes experts from prestigious institutions and companies, enhancing the company's capabilities in AI model development and deployment [7]. Investor Perspectives - Investors highlight the team's combination of academic excellence and practical experience, noting the significant advantages of the disease prediction model in lightweight deployment and multimodal integration [8]. - The company's approach aligns well with the development plans for the digital health industry in Hangzhou, focusing on efficient iterations of health insurance products [8].